Malin Corporation PLC Holding(s) in Company

RNS Number : 1151B

Malin Corporation PLC

26 January 2024

 

Malin Corporation plc

 

Holding(s) in Company

 

Dublin-Ireland, 26 January 2024: Malin Corporation plc. (Euronext Growth Dublin:MLC) ("Malin", the "Company"), received notification today from Mr Sean O'Driscoll  that, as of 26 January 2024, he holds an interest in 1,750,000 ordinary shares of €0.01 each which represents 9.26%* of the issued share capital of Malin.

  

*This percentage shareholding is based on a share in issue figure of 18,889,274 ordinary shares.

ENDS

 

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com 

For further information please contact:

Malin

Fiona Dunlevy, Executive Director / Company Secretary

Tel: [phone]

[e-mail]

 

Davy Corporate Finance (Euronext Growth Listing Sponsor & Joint Broker)

Brian Garrahy / Daragh O'Reilly

Tel: [phone]

 

Liberum (Joint Broker)

Phil Walker / Ben Cryer

Tel: [phone]

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

HOLQQLFLZFLEBBB